These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4162817)

  • 21. [Treatment of hyperplasia of the male breast].
    Wojciechowski K; Twardosz W; Walczak M
    Pol Przegl Chir; 1968 Sep; 40(9):1003-9. PubMed ID: 5701869
    [No Abstract]   [Full Text] [Related]  

  • 22. [Investigation of trace elements in hair of patients with prostate carcinoma, benign prostatic hypertrophy, and normal controls].
    Ouyang SY; Li SL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):279-80. PubMed ID: 12212167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiology of prostate cancer].
    Ilić M; Vlajinac H
    Vojnosanit Pregl; 1995; 52(6):585-9. PubMed ID: 8644485
    [No Abstract]   [Full Text] [Related]  

  • 25. Cirrhosis of the liver in Japan.
    Yoshida T; Kawata H; Fukui O; Koizumi T; Asada M; Wada M
    Acta Hepatosplenol; 1965; 12(5):268-78. PubMed ID: 5866828
    [No Abstract]   [Full Text] [Related]  

  • 26. A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.
    Gsur A; Preyer M; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):497-8. PubMed ID: 12010866
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical and morphological studies on gynecomastia].
    Shinohara K; Ito E; Shinohara M
    Bruns Beitr Klin Chir (1971); 1967 Sep; 215(2):173-86. PubMed ID: 4172942
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on incidence of benign prostatic hypertrophy and prostatic cancer in cold districts. I. Mass examination of prostate in Tanno town].
    Furuya S; Yokoyama E; Kumamoto Y; Aoki S; Tanaka N
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):957-64. PubMed ID: 2416978
    [No Abstract]   [Full Text] [Related]  

  • 29. [Psychic effects of estrogen on patients with prostatic diseases].
    Petersen P
    Dtsch Med Wochenschr; 1965 Dec; 90(52):2309-12. PubMed ID: 5851379
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
    Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
    Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genital and urinary tract diseases and prostate cancer risk.
    Pelucchi C; Talamini R; Negri E; Franceschi S; La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):254-7. PubMed ID: 16679869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Constitutional studies on tumors of the prostate. II. On hair patterns and other features].
    Ogawa M
    Hinyokika Kiyo; 1967 Jul; 13(7):507-15. PubMed ID: 4169941
    [No Abstract]   [Full Text] [Related]  

  • 33. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
    Madersbacher S
    Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic obstruction in Sudan.
    Kambal A
    Br J Urol; 1977 Apr; 49(2):139-41. PubMed ID: 66962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormone therapy for prostatic carcinoma and hypertrophy].
    Hanschke HJ
    Dtsch Med Wochenschr; 1969 Mar; 94(13):677-8. PubMed ID: 4180637
    [No Abstract]   [Full Text] [Related]  

  • 37. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Benign hypertrophy of the prostate (BHP) in France: a challenge in organization of care].
    Costa P
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():1-3. PubMed ID: 16649581
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the causal genesis of prostatic hypertrophy. I].
    Kaufmann J
    Z Urol Nephrol; 1968 Mar; 61(3):171-84. PubMed ID: 4173128
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia.
    Galić J; Simunović D
    Coll Antropol; 2008 Dec; 32(4):1195-202. PubMed ID: 19149228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.